especially if they belong to that group of patients who can be treated as effectively with one form as the other. This paper will present the clinical experience with patients on CAPD in the Toronto Western Hospital program.
PATIENTS AND TECHNIQUES
Between September 1977 and June 1980, 115 patients (60 females and 55 males) were admitted to our program. They ranged in age from 6 to 78 years, with an average of 49.7. Their time on CAPD varied from I to 30 months (average 11.4 months). It is interesting to note that 7.8 per cent had polycystic kidneys and 8.7 per cent were diabetic.
All were dialyzed using the Toronto Western Hospital technique for CAPD 2. The major modifications of the original technique were as follows: (1) The connection tubing was changed every four weeks in hospital by the nurses instead of once a week by the patients at home; (2) the dressings were changed every two days and in some patients once a week instead of once a day; (3) The table shows the biochemical control achieved with CAPD and the effect that decreasing the dialysis volume from 8 to 6 litres a day has on the biochemical values of 15 patients. The changes were significant only for BUN and serum creatinine. Continuous ambulatory peritoneal dialysis is an excellent means of controlling serum potassium, even with 6 litres of dialysate a day. CO2 levels were maintained in a slightly acidotic range because the concentration of lactate in the dialysate was relatively low, 35 mEq/1; perhaps the concentration should be higher (40 mEq/l).
Continuous ambulatory peritoneal dialysis with small doses of antacids (2-4 g/day) provides satisfactory control of serum phosphorus. The control of serum calcium is also satisfactory. However, a higher concentration of calcium may be desirable, because we have observed that hyperparathyroidism persists in most patients on CAPD when dialysed with a dialysate that has a calcium concentration of 6 mg/dl.
During the first 3 months on CAPD the hemoglobin, hematocrit and red blood cell count increase, but level off thereafter. It is interesting to note, however, that there is a slight decline at the later stages for some reason that is not clear ( Figure I ). Despite the removal of immunoglobulins by CAPD, the plasma immunoglobulin levels remain within normal ranges.
Serum cholestrol concentration increased slightly, from an initial value of 205 mg/dl to around 280 mg/dl, but declined after the 18th month. Simitarly, serum triglycerides initially are slightly increased, but increase further to between 400 and 500 mg/dl after 6 months on CAPD. As the high standard errors indicate, a few patients have triglyceride levels about 1000 mg/dl. This hypertriglyceridemia, which may predispose to accelerated atherosclerosis, may be related to the continuous absorption of dextrose from the dialysate. If dextrose is indeed responsible, we should consider the use of other osmotic agents, e.g. mixed aminoacid solutions, as we suggested in the past '. The potential advantages of an amino-acid-containing dialysate are the elimination of the side effects of dextrose, and the enhancement of protein synthesis and improvement of hypoproteinemia. Our experience with humans and with animals indicates that an amino-acidcontaining dialysate is as effective as a dextrose dialysate in producing ultrafiltration and removing urea and creatinine.
CALCIUM AND BONE STATUS OF PATIENTS ON CAPD.
A dialysate with a calcium concentration of 6 mg% keeps the patient in a negative peritoneal calcium balance ranging between 30 and 50 mg a day 3. Radioligical investigations have shown that subperiosteal resorption continues in most of them, and the hyperparathyroid bone disease persists or progresses in these patients despite the good control of serum phosphorus. In contrast to osteitis fibrosa, osteomalacia seems to respond to treatment with CAPD. Two of our patients who had osteomalacia, histologically confirmed, and multiple rib fractures that did not respond to treatment with 1,25 dihydroxyvitamin D or DHT achieved healing of their fractures while on CAPD.
Vascular calcifications do not progress in patients on CAPD, probably because their calcium x phosphorus product is maintained within the normal range.
NUTRITIONAL STATUS OF PATIENTS ON CAPD There is a gradual increase in mean body weight which probably reflects the increase in appetite which develops after the institution of CAPD and the absorption of dextrose. Nitrogen balance studies, done over short periods, indicate that these patients are in a positive nitrogen balance 6 by staff every month, the introduction of the Travenol Titanium adapter, and the decrease in the number of exchanges. Whatever the reason(s), we seem to be reaching the point where peritonitis will cease to be the major complication of CAPD; for example, we have maintained 22 of our patients on CAPD for one year and 3 of them for 2 years without a single episode of peritonitis.
MECHANICAL OR DIALYSIS-RELATED COMPLICATIONS Catheter-tubing separations were encountered until we introduced the technique of connecting the Luer end of the tubing with the permanent catheter. Recently, we adopted the Travenol Titanium Luer lock connector, which has eliminated this problem. Skin exit site infection is still a serious problem and it may require catheter replacement or may lead to peritonitis. Bloody effluent may be related to menstruation. Early or late dialysate leak through the exit site may be prevented by the introduction of the modified Toronto Western Hospital catheter, which has a Dacron disc at the base of the peritoneal cuff to seal the peritoneal hole. (Fig 3) .
MEDICAL COMPLICATIONS OF CAPD
Although most of the cardiovascular complications were observed in our older patients, it is still possible that these may be related to lipid abnormalities. They included symptomatic hypotension (33), arrhythmia (8), pericarditis (5), myocardial infarction (5), unstable angina (5) and reduced circulation to legs(4). Our research into symptomatic hypotension suggests that in most of these patients it is related to volume depletion~.
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